PDE3B
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B
Also known as: HcGIP1, PDE3B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13370
- Gene
- PDE3B
- Ensembl
- ENSG00000152270
- Chromosome
- 11
- Canonical length
- 1112 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables 3',5'-cyclic-AMP phosphodiesterase activity. Involved in several processes, including negative regulation of angiogenesis; negative regulation of lipid catabolic process; and regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1112 residues, UniProt reviewed canonical sequence.
>Q13370|PDE3B
1 MRRDERDAKA MRSLQPPDGA GSPPESLRNG YVKSCVSPLR QDPPRGFFFH LCRFCNVELR
61 PPPASPQQPR RCSPFCRARL SLGALAAFVL ALLLGAEPES WAAGAAWLRT LLSVCSHSLS
121 PLFSIACAFF FLTCFLTRTK RGPGPGRSCG SWWLLALPAC CYLGDFLVWQ WWSWPWGDGD
181 AGSAAPHTPP EAAAGRLLLV LSCVGLLLTL AHPLRLRHCV LVLLLASFVW WVSFTSLGSL
241 PSALRPLLSG LVGGAGCLLA LGLDHFFQIR EAPLHPRLSS AAEEKVPVIR PRRRSSCVSL
301 GETAASYYGS CKIFRRPSLP CISREQMILW DWDLKQWYKP HYQNSGGGNG VDLSVLNEAR
361 NMVSDLLTDP SLPPQVISSL RSISSLMGAF SGSCRPKINP LTPFPGFYPC SEIEDPAEKG
421 DRKLNKGLNR NSLPTPQLRR SSGTSGLLPV EQSSRWDRNN GKRPHQEFGI SSQGCYLNGP
481 FNSNLLTIPK QRSSSVSLTH HVGLRRAGVL SSLSPVNSSN HGPVSTGSLT NRSPIEFPDT
541 ADFLNKPSVI LQRSLGNAPN TPDFYQQLRN SDSNLCNSCG HQMLKYVSTS ESDGTDCCSG
601 KSGEEENIFS KESFKLMETQ QEEETEKKDS RKLFQEGDKW LTEEAQSEQQ TNIEQEVSLD
661 LILVEEYDSL IEKMSNWNFP IFELVEKMGE KSGRILSQVM YTLFQDTGLL EIFKIPTQQF
721 MNYFRALENG YRDIPYHNRI HATDVLHAVW YLTTRPVPGL QQIHNGCGTG NETDSDGRIN
781 HGRIAYISSK SCSNPDESYG CLSSNIPALE LMALYVAAAM HDYDHPGRTN AFLVATNAPQ
841 AVLYNDRSVL ENHHAASAWN LYLSRPEYNF LLHLDHVEFK RFRFLVIEAI LATDLKKHFD
901 FLAEFNAKAN DVNSNGIEWS NENDRLLVCQ VCIKLADING PAKVRDLHLK WTEGIVNEFY
961 EQGDEEANLG LPISPFMDRS SPQLAKLQES FITHIVGPLC NSYDAAGLLP GQWLEAEEDN
1021 DTESGDDEDG EELDTEDEEM ENNLNPKPPR RKSRRRIFCQ LMHHLTENHK IWKEIVEEEE
1081 KCKADGNKLQ VENSSLPQAD EIQVIEEADE EELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE3B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 61 nTPM
- liver: 24 nTPM
- colon: 24 nTPM
- lymph node: 14 nTPM
- salivary gland: 13 nTPM
- breast: 12 nTPM
Single-cell type
- adipocytes: 2,847 nCPM
- neutrophils: 1,417 nCPM
- t-cells: 827 nCPM
- thyrotrophs: 539 nCPM
- salivary acinar cells: 515 nCPM
- microglia: 490 nCPM
Immune cell
- naive CD4 T-cell: 6.3 nTPM
- naive CD8 T-cell: 5.7 nTPM
- neutrophil: 3.9 nTPM
- T-reg: 3.5 nTPM
- memory CD4 T-cell: 3.1 nTPM
- eosinophil: 2.5 nTPM
Brain region
- cerebellum: 32 nTPM
- medulla oblongata: 9.7 nTPM
- white matter: 9.5 nTPM
- hypothalamus: 9.3 nTPM
- cerebral cortex: 9.1 nTPM
- spinal cord: 8.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.05
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- G protein-coupled receptor signaling pathway
- insulin receptor signaling pathway
- negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- negative regulation of angiogenesis
- negative regulation of cAMP/PKA signal transduction
- negative regulation of cell adhesion
- negative regulation of cell adhesion mediated by integrin
- negative regulation of lipid catabolic process
- regulation of angiogenesis
- regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- 3',5'-cyclic-nucleotide phosphodiesterase activity
- metal ion binding
- protein kinase B binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDE3B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE3B as an antibody target. Whether an autoantibody or antibody against PDE3B could matter depends on whether native PDE3B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE3B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE3B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...